Seguir
Vanessa Kiyomi Ota
Vanessa Kiyomi Ota
Department of Morphology and Genetics
Dirección de correo verificada de unifesp.br
Título
Citado por
Citado por
Año
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...
Nature 604 (7906), 502-508, 2022
10802022
Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis
C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ...
International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015
1332015
Early life adversity, genomic plasticity, and psychopathology
G Turecki, VK Ota, SI Belangero, A Jackowski, J Kaufman
The Lancet Psychiatry 1 (6), 461-466, 2014
1252014
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
C Noto, M Maes, VK Ota, AL Teixeira, RA Bressan, A Gadelha, E Brietzke
The World Journal of Biological Psychiatry 16 (6), 422-429, 2015
962015
Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
MN Noto, M Maes, SOV Nunes, VK Ota, AC Rossaneis, WA Verri Jr, ...
European Neuropsychopharmacology 29 (3), 416-431, 2019
812019
Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone
C Noto, VK Ota, A Gadelha, MN Noto, DS Barbosa, KL Bonifácio, ...
Journal of psychiatric research 68, 210-216, 2015
742015
Effects of depression on the cytokine profile in drug naive first-episode psychosis
C Noto, VK Ota, ML Santoro, BB Ortiz, LB Rizzo, CH Higuchi, Q Cordeiro, ...
Schizophrenia research 164 (1-3), 53-58, 2015
722015
Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naïve first episode psychosis
C Noto, VK Ota, ML Santoro, ES Gouvea, PN Silva, LM Spindola, ...
Molecular neurobiology 53 (8), 5701-5709, 2016
702016
Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia
A Zugman, A Gadelha, I Assunção, J Sato, VK Ota, DL Rocha, JJ Mari, ...
Schizophrenia research 148 (1-3), 81-86, 2013
672013
Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
E Asevedo, LB Rizzo, A Gadelha, RB Mansur, VK Ota, AA Berberian, ...
Physiology & behavior 129, 194-198, 2014
642014
Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
ML Santoro, V Ota, S de Jong, C Noto, LM Spindola, F Talarico, E Gouvea, ...
Translational psychiatry 8 (1), 174, 2018
602018
Implication of LRRC4C and DPP6 in neurodevelopmental disorders
G Maussion, C Cruceanu, JA Rosenfeld, SC Bell, F Jollant, J Szatkiewicz, ...
American Journal of Medical Genetics Part A 173 (2), 395-406, 2017
482017
DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs
VK Ota, LN Spíndola, A Gadelha, AF dos Santos Filho, ML Santoro, ...
Schizophrenia research 142 (1-3), 206-208, 2012
442012
Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis
FF Brinholi, C Noto, M Maes, KL Bonifácio, E Brietzke, VK Ota, A Gadelha, ...
Schizophrenia research 166 (1-3), 225-230, 2015
432015
Changes in gene expression and methylation in the blood of patients with first-episode psychosis
VK Ota, C Noto, A Gadelha, ML Santoro, LM Spindola, ES Gouvea, ...
Schizophrenia research 159 (2-3), 358-364, 2014
432014
Vascular loops in the anterior inferior cerebellar artery, as identified by magnetic resonance imaging, and their relationship with otologic symptoms
L Abreu Junior, CH Kuniyoshi, AB Wolosker, ML Borri, A Antunes, ...
Radiologia Brasileira 49, 300-304, 2016
382016
Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
CT Matsuzaka, D Christofolini, VK Ota, A Gadelha, AA Berberian, C Noto, ...
Brazilian Journal of Psychiatry 39, 302-308, 2017
362017
Accessing gene expression in treatment-resistant schizophrenia
PN Moretti, VK Ota, ES Gouvea, M Pedrini, ML Santoro, F Talarico, ...
Molecular neurobiology 55, 7000-7008, 2018
332018
A molecular model for neurodevelopmental disorders
CO Gigek, ES Chen, VK Ota, G Maussion, H Peng, K Vaillancourt, ...
Translational Psychiatry 5 (5), e565-e565, 2015
302015
A systematic review on the effects of social discrimination on telomere length
BM Coimbra, CM Carvalho, VK Ota, T Vieira-Fonseca, A Bugiga, AF Mello, ...
Psychoneuroendocrinology 120, 104766, 2020
292020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20